CVE-2025-62287

CVE-2025-62287 is a medium-severity vulnerability in Oracle Life Sciences Inform with a CVSS 3.x base score of 6.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-306.

Key facts

Description

Vulnerability in the Oracle Life Sciences InForm product of Oracle Health Sciences Applications (component: Web Server). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Oracle Life Sciences InForm, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. CVSS 3.1 Base Score 6.1 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N).

Frequently asked questions

What is CVE-2025-62287?
Vulnerability in the Oracle Life Sciences InForm product of Oracle Health Sciences Applications (component: Web Server). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Oracle Life Sciences InForm, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. CVSS 3.1 Base Score 6.1 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N).
How severe is CVE-2025-62287?
CVE-2025-62287 has a CVSS 3.x base score of 6.1, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2025-62287 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (7th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2025-62287?
CVE-2025-62287 affects Oracle Life Sciences Inform. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2025-62287?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2025-62287 have an EU (EUVD) identifier?
Yes. CVE-2025-62287 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-35223.
When was CVE-2025-62287 published?
CVE-2025-62287 was published on 2025-10-21 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Oracle Life Sciences Inform

All CVEs affecting Oracle Life Sciences Inform →

Other CWE-306 (Missing Authentication for Critical Function) vulnerabilities

Browse all CWE-306 (Missing Authentication for Critical Function) vulnerabilities →